Swiss Paper and Forestry Products Stock News

HIAG Immobilien Holding's (VTX:HIAG) stock is up by a considerable 12% over the past three months. As most would know...

Ypsomed Holding (SWX:YPSN) released its half-year earnings, reporting net income of CHF 139 million compared to CHF 33 million a year earlier. Earnings per share also rose sharply in the same period. See our latest analysis for Ypsomed Holding. Ypsomed Holding’s robust jump in profits seems to have caught the market’s eye, with the share price gaining nearly 5% over the past month. However, longer-term momentum has faded, reflected in a 1-year total shareholder return of -7%. Still, investors...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Zurich Insurance Group (SWX:ZURN) is gaining attention as it pushes forward with its 2025 to 2027 strategy, citing disciplined execution and improvements in its retail business profitability. The company is also ramping up growth efforts across segments. See our latest analysis for Zurich Insurance Group. The recent wave of strategic initiatives, including the appointment of a new Asia-Pacific chief claims officer and a focus on Zurich Insurance Group’s specialty unit, appears to have renewed...

SIG Group (SWX:SIGN) has named Mikko Keto as its next Chief Executive Officer, drawing attention across the market. His background in driving business transformation and operational change has investors looking closely at what this could mean for SIG’s direction. See our latest analysis for SIG Group. The announcement of Mikko Keto’s appointment sparked a surge in SIG Group’s share price, jumping over 11% in the past week alone. While that burst of optimism stands out, it follows a...

Partners Group Holding (SWX:PGHN) has named Nicholas Smith Wang as Partner and Co-Head of its Private Equity Technology Vertical. This move underscores the firm's focus on expanding its technology investment capabilities with experienced senior leadership. See our latest analysis for Partners Group Holding. Partners Group's appointment of Nicholas Smith Wang comes at a time when momentum around the stock has been mixed. The company’s 1-year total shareholder return stands at -24.6%, signaling...

Key Insights The considerable ownership by private companies in Dottikon ES Holding indicates that they collectively...

As European markets navigate the complexities of cooling sentiment on artificial intelligence and mixed economic indicators, the pan-European STOXX Europe 600 Index has managed to rise by 1.77%, buoyed by relief over the U.S. federal government reopening. In this environment, identifying promising small-cap stocks requires a keen eye for companies that demonstrate resilience and adaptability amid fluctuating market conditions, particularly those with robust fundamentals that can weather...

Even though Montana Aerospace AG ( VTX:AERO ) posted strong earnings, investors appeared to be underwhelmed. Our...

One of the biggest stories of last week was how ams-OSRAM AG ( VTX:AMS ) shares plunged 23% in the week since its...

Novartis (SWX:NOVN) shares recently edged lower, continuing a slight downtrend seen over the past week and month. Investors are now weighing the implications of these moves in relation to the company’s track record and recent financial performance. See our latest analysis for Novartis. Even with Novartis’s recent slip, the bigger picture looks resilient, with a steady year-to-date share price return of nearly 13 percent and a strong 1-year total shareholder return of 13.6 percent. While...

Sika has successfully completed the placement of CHF 600 million in bonds across three tranches, with maturities spanning from 2027 to 2034 and yields ranging from 0.45% to 1.16%, which will be listed on the SIX Swiss Exchange. This multi-tranche bond issuance was designed to optimize Sika’s funding structure and enhance financial flexibility by lowering overall group-wide funding costs. We’ll explore how Sika’s strengthened funding profile may influence its investment narrative and future...

In the past week, Roche announced a series of major developments, including the European Commission's conditional approval of Lunsumio subcutaneous for relapsed/refractory follicular lymphoma, positive phase III results for fenebrutinib in multiple sclerosis, and a new clinical trial collaboration with KaliVir Immunotherapeutics to advance novel combination immunotherapies in oncology. These milestones highlight Roche's continued expansion across oncology and neurology, with new treatment...

Avolta (SWX:AVOL) is making moves across the Asia Pacific, entering Japan’s Kansai Airport with new retail ideas and debuting refreshed stores in Perth. The company’s latest loyalty partnership in Thailand also signals deeper customer engagement. See our latest analysis for Avolta. While Avolta’s latest moves in Japan, Australia, and Thailand have made headlines, the market story goes deeper. The stock’s year-to-date share price return sits at an impressive 18.96%, and the one-year total...

Barry Callebaut (SWX:BARN) stock came into focus after Goldman Sachs initiated coverage with a Buy rating, signaling increased attention from market participants. This move suggests broader confidence in the company’s mid-term prospects and ongoing transformation. See our latest analysis for Barry Callebaut. Momentum has started to build for Barry Callebaut, with its strategic partnership with NotCo AI and a recently affirmed dividend highlighting its transformation agenda. While the 90-day...

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

At the Bloomberg New Economy Forum in Singapore, ABB recently reaffirmed its mid-term revenue growth target of 5–7% annually on a comparable basis and raised its operational earnings margin goal to 18–22%. While the increased profitability target marked a positive step, the decision not to lift sales growth guidance, despite stronger targets from peers, stood out to industry observers and investors. We'll examine how ABB's decision to maintain its sales growth target, even as peers raise...

On November 18, 2025, u-blox Holding AG (SWX:UBXN) was removed from the S&P Global BMI Index, a widely tracked global benchmark for equities. This index exclusion can influence trading behavior, as passive funds often adjust their portfolios to align with index changes, potentially impacting liquidity. We'll now consider how the index removal and subsequent fund adjustments may shape u-blox Holding's broader investment narrative. We've found 15 US stocks that are forecast to pay a dividend...

As global markets navigate the aftermath of the longest U.S. government shutdown in history, investors are observing mixed performances across major indices, with small-cap stocks particularly underperforming due to heightened sensitivity to interest rate movements and ongoing concerns about elevated valuations. In this environment, identifying high-growth tech stocks requires a focus on companies that can demonstrate resilience and adaptability amid economic uncertainties and shifting market...

Key Insights Given the large stake in the stock by institutions, Landis+Gyr Group's stock price might be vulnerable to...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Galderma recently presented new clinical data from its Restylane and Sculptra portfolios at the American Society for Dermatologic Surgery 2025 Annual Meeting in Chicago, including results that supported the recent FDA approval of Restylane Lyft for chin augmentation in adults. This new data not only highlights high patient satisfaction and durable results for the company’s injectable aesthetics but also addresses emerging needs among patients experiencing facial changes following...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...